• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单一片剂抗逆转录病毒治疗方案吞咽容易度的初步比较。

Pilot comparison of the ease of swallowing of single tablet antiretroviral regimens.

机构信息

Medicine/Infectious Diseases Division, Henry Ford Hospital/Wayne State University, Detroit, MI, USA.

Medical School, Michigan State University, Detroit, MI, USA.

出版信息

AIDS Care. 2022 Mar;34(3):404-407. doi: 10.1080/09540121.2021.1939258. Epub 2021 Jun 14.

DOI:10.1080/09540121.2021.1939258
PMID:34125632
Abstract

Daily adherence to lifelong antiretroviral therapy (ART) is required to achieve long term treatment success. However, patient preferences for ART tablet size have not been well studied. Our study assessed factors associated with the ease of swallowing (EoS) and tolerability of two placebo tablets representing and matching B/F/TAF (BPT) and DTG/ABC/3TC (DPT). Fifty ART-naïve patients were randomized into a two-period cross-over study. Likert scale (1-5) questionnaires were administered to assess patient factors influencing the ease of swallowing, adherence, home medications, medication preferences and perceptions. Comparisons were done using Student -tests and ordinal regression. Participants were 64% female, 61% white, mean age 43 years, and taking a mean (median) of 4(1) pills/day. BPT was reported to be easier than DPT with ease of swallowability 1.76 vs. 2.42 (< 0.001) (1 = very easy). DPT tablet was correctly perceived as larger than BPT (< 0.001); with both tablets perceived as smaller than actual size (< 0.001). EoS of either tablet was positively associated with the EoS of the largest home tablet medication ( = 0.021,  = 0.03). Patient's perceptions of EoS can affect their medication adherence, especially in HIV, and should be considered in treatment regimens.

摘要

患者需要每天坚持使用抗逆转录病毒疗法(ART)才能实现长期治疗成功。然而,患者对 ART 片剂大小的偏好尚未得到充分研究。我们的研究评估了与两种代表并匹配 B/F/TAF(BPT)和 DTG/ABC/3TC(DPT)的安慰剂片剂的吞咽舒适度(EoS)和耐受性相关的因素。50 名初治的 ART 患者被随机分为两期交叉研究。采用李克特量表(1-5)问卷评估影响吞咽舒适度、依从性、家庭用药、药物偏好和认知的患者因素。采用学生 t 检验和有序回归进行比较。参与者中女性占 64%,白人占 61%,平均年龄 43 岁,平均(中位数)每天服用 4(1)片。BPT 的吞咽舒适度报告为 1.76,明显优于 DPT 的 2.42(<0.001)(1=非常容易)。DPT 片剂被正确认为比 BPT 更大(<0.001);两种片剂均被认为比实际尺寸小(<0.001)。任何一种片剂的 EoS 与最大的家庭用药片剂的 EoS 呈正相关( =0.021, =0.03)。患者对 EoS 的认知会影响他们的用药依从性,尤其是在 HIV 中,应在治疗方案中考虑到这一点。

相似文献

1
Pilot comparison of the ease of swallowing of single tablet antiretroviral regimens.单一片剂抗逆转录病毒治疗方案吞咽容易度的初步比较。
AIDS Care. 2022 Mar;34(3):404-407. doi: 10.1080/09540121.2021.1939258. Epub 2021 Jun 14.
2
Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries.新处方 HIV 治疗的真实世界依从性和持久性:美国医疗补助受益人群中单一片剂与多片剂方案比较。
AIDS Res Ther. 2020 Apr 1;17(1):12. doi: 10.1186/s12981-020-00268-1.
3
Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients.多替拉韦/阿巴卡韦/拉米夫定单片方案在 HIV-1 成人感染患者真实队列中的疗效、安全性和成本。
Ann Pharmacother. 2020 Jul;54(7):633-643. doi: 10.1177/1060028019896638. Epub 2020 Jan 8.
4
Comparison of adherence to generic multi-tablet regimens vs. brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients.比较艾滋病毒感染患者中,通过拆分或不拆分固定剂量组合,服用通用多片方案与可能包含通用抗逆转录病毒药物的品牌多片方案及品牌单片方案的依从性。
Fundam Clin Pharmacol. 2018 Aug;32(4):450-458. doi: 10.1111/fcp.12363. Epub 2018 Apr 23.
5
Factor Analysis of Patients Who Find Tablets or Capsules Difficult to Swallow Due to Their Large Size: Using the Personal Health Record Infrastructure of Electronic Medication Notebooks.因片剂或胶囊尺寸过大而难以吞咽的患者的因素分析:利用电子药历的个人健康记录基础设施
J Med Internet Res. 2024 Apr 24;26:e54645. doi: 10.2196/54645.
6
A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.一项针对使用毒品的 HIV 感染者每日药物负担和最佳抗逆转录病毒治疗依从性可能性的纵向分析。
J Addict Med. 2018 Jul/Aug;12(4):308-314. doi: 10.1097/ADM.0000000000000403.
7
Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection.抗逆转录病毒治疗初治 HIV 感染患者的药物计数和临床结局。
HIV Med. 2018 Feb;19(2):132-142. doi: 10.1111/hiv.12562. Epub 2017 Nov 6.
8
Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.融合的力量:新型 HIV 联合用药及其对实践的影响。
Pharmacotherapy. 2018 Jan;38(1):86-107. doi: 10.1002/phar.2055. Epub 2017 Dec 11.
9
Dysphagia and pill swallowing in HIV/AIDS in South Africa: Results of a scoping review.南非艾滋病病毒/艾滋病患者的吞咽困难和吞服药片问题:范围综述结果。
S Afr J Commun Disord. 2023 Mar 31;70(1):e1-e6. doi: 10.4102/sajcd.v70i1.955.
10
Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.单一片剂方案使用率的增加以及与艾滋病病毒感染女性相关的与依从性相关结局的改善。
J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):587-96. doi: 10.1097/QAI.0000000000000082.

引用本文的文献

1
Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018-2020.2018 - 2020年《平价医疗法案》医保市场计划中新型一线单片式HIV抗逆转录病毒疗法的可及性。
J Pharm Policy Pract. 2023 Apr 20;16(1):57. doi: 10.1186/s40545-023-00559-8.
2
Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study.在健康成年人中,比克替拉韦、恩曲他滨、替诺福韦艾拉酚胺的溶解和压碎单片剂的生物利用度:SOLUBIC 随机交叉研究。
J Antimicrob Chemother. 2022 Dec 23;78(1):161-168. doi: 10.1093/jac/dkac369.
3
Identifying and addressing pill aversion in adults without physiological-related dysphagia: A narrative review.
识别和解决无生理相关吞咽困难的成年人的服药抵触情绪:叙述性综述。
Br J Clin Pharmacol. 2022 Dec;88(12):5128-5148. doi: 10.1111/bcp.15463. Epub 2022 Aug 2.